Results 171 to 180 of about 111,828 (202)

Plasminogen activator inhibitor 1 in thrombotic disease

Current Opinion in Hematology, 1996
Impaired fibrinolytic function, mainly due to an elevation of plasma plasminogen activator inhibitor 1 concentration, is a common finding in patients with thrombotic disease. In patients subjected to hip surgery, preoperatively increased levels of plasminogen activator inhibitor 1 seem to be predictive of postoperative deep venous thrombosis.
openaire   +2 more sources

Plasminogen Activator Inhibitor 1 and Atherothrombosis

Thrombosis and Haemostasis, 1993
I, Juhan-Vague, M C, Alessi
openaire   +2 more sources

Plasminogen Activator Inhibitor-1

2017
Deniz Agirbasli, Mehmet Agirbasli
openaire   +1 more source

Recombinant Plasminogen Activator Inhibitor-1

Drugs of the Future, 1992
T.M. Reilly, A.L. Racanelli, S.A. Mousa
openaire   +1 more source

Plasminogen Activator Inhibitor-1

2007
S.J. Enna, David B. Bylund
openaire   +1 more source

P55. Plasminogen activator inhibitor-1

Blood Coagulation & Fibrinolysis, 1996
R. W. Faint, F. M. Bent, C. S. Barnes, P. Bevan, J. S. Bryans, P. A. Charlton, A. J. Folkes, S. J. Machin, I. Mackie   +8 more
openaire   +1 more source

Vascular Regulation of Plasminogen Activator Inhibitor-1 Activity

Seminars in Thrombosis and Hemostasis, 1994
J M, Edelberg, D C, Sane, S V, Pizzo
openaire   +2 more sources

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

Lancet, The, 1999
Jan A Hazelzet, Michael Levin
exaly  

Promoter (4G/5G) Plasminogen Activator Inhibitor-1 Genotype and Plasminogen Activator Inhibitor-1 Levels in Blacks, Hispanics, and Non-Hispanic Whites

Circulation, 2003
Russell P Tracy
exaly  

Plasminogen Activator Inhibitor 1

2018
openaire   +1 more source